Patisiran
Full Prescribing Information for ONPATTRO® (patisiran)
Click below to learn more about the use of patisiran in patients with the polyneuropathy of ATTRv (also known as hATTR) amyloidosis.
If you are unable to find the answer to your specific question about patisiran, please connect with us by reaching out to your local Medical Science Liaison or contacting our Medical Information team.
More Information
For more information about data regarding patisiran, please visit our Congresses and Publications resource page.
APOLLO Post-Hoc Analysis by Baseline Polyneuropathy Severity
A post-hoc analysis of the APOLLO trial was performed to evaluate the use of patisiran compared to placebo by baseline NIS quartile in patients with the the polyneuropathy of hATTR. This infographic summarizes the post-hoc analysis results, which were published in the journal Amyloid.
